Related Experiment Video

Updated: Dec 21, 2025

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
07:53

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

4.6K

Change in blood test results prior to diagnosis in multiple myeloma

Catherine Atkin1, Elizabeth Sapey1, Alex Richter1

  • 1University of Birmingham, Birmingham, UK.

Clinical Medicine (London, England)
|May 16, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.9K
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

30.2K

Related Experiment Videos

Last Updated: Dec 21, 2025

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
07:53

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

4.6K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.9K
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

30.2K

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.8K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.8K

Articles linked to this work by shared authors, journal, and citation graph.

Sarcopenia in older adults admitted to acute medical unit: a prospective observational study of feasibility and clinical outcomes.

Frontiers in medicine·2026

Validation of federated analytics across secure data environments: A comparative study of synthetic healthcare datasets using machine learning and general linear models.

Digital health·2026

Enhancing the accuracy of a multivariable prediction model to identify medical patients suitable for same day emergency care services.

BMJ health & care informatics·2026

Does hourly variation in ambient nitrogen dioxide increase the risk of acute asthma hospitalisations? A time-series study of Birmingham and Solihull, UK.

BMJ open·2026

Dysfunctional neutrophil response in COVID-19 infection varies by subtype.

Journal of leukocyte biology·2026

Impact of social deprivation on quality indicators for the acute medical take.

Postgraduate medical journal·2026

Investigation of suspected pulmonary embolus - imaging frequency and diagnostic yield over 10 years in a major UK teaching hospital.

Clinical medicine (London, England)·2026

Promoting clinical academic careers and medical research skills through a dedicated research training programme: Outcomes from the MEDICORE programme.

Clinical medicine (London, England)·2026

Sink or swim: Making sense of the NICE intravenous fluid guidelines as a Foundation Year Doctor.

Clinical medicine (London, England)·2026

The economic imperative for an AI Productivity Index in healthcare: Beyond clinical promise to fiscal accountability.

Clinical medicine (London, England)·2026

What is new in tuberculosis?

Clinical medicine (London, England)·2026

Risk factors of clonal hematopoiesis of indeterminate potential.

Clinical medicine (London, England)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us